|
Corporate News
21-Dec-18
|
|
|
|
|
|
|
Unichem Laboratories gets USFDA approval for Pramipexole Dihydrochloride Tablets
|
|
|
|
Unichem Laboratories has received final ANDA approval for its Pramipexole Dihydrochloride Tablets, 0.125 mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg and 1.5 mg from the United States Food and Drug Administration to market a generic version of Boehringer Ingelheim Pharmaceuticals Inc.'s Mirapex Tablets, 0.125 mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg and 1.5 mg.
|
|
Previous News |
Sun Pharmaceuticals Industries Ltd Falls 1.71%
(
Hot Pursuit
-
20-Jun-24
09:30
)
|
|
Unichem Laboratories reports consolidated net loss of Rs 23.37 crore in the June 2022 quarter
(
Results
-
Announcements
09-Aug-22
15:33
)
|
|
Unichem Lab net loss widens to Rs 129 cr in Q4
(
Hot Pursuit
-
22-May-24
15:30
)
|
|
Unichem Laboratories reports standalone net loss of Rs 23.28 crore in the June 2022 quarter
(
Results
-
Announcements
09-Aug-22
15:01
)
|
|
Board of Unichem Laboratories appoints director
(
Corporate News
-
20-Mar-23
11:16
)
|
|
Unichem Laboratories reports consolidated net loss of Rs 129.31 crore in the March 2024 quarter
(
Results
-
Announcements
22-May-24
15:19
)
|
|
Unichem Laboratories to convene board meeting
(
Corporate News
-
28-Jan-23
12:58
)
|
|
Unichem Laboratories standalone net profit declines 66.80% in the September 2018 quarter
(
Results
-
Announcements
30-Oct-18
16:59
)
|
|
Board of Unichem Laboratories approves allotment of shares under ESOS
(
Corporate News
-
21-Jan-17
14:07
)
|
|
Unichem Laboratories reports consolidated net loss of Rs 0.67 crore in the June 2023 quarter
(
Results
-
Announcements
14-Jul-23
18:40
)
|
|
Unichem Laboratories to declare Quarterly Result
(
Corporate News
-
10-Jul-19
11:12
)
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|